Home
Cataract
Cornea
Glaucoma
Refractive
Retina
Practice Management
Welcome Guest
Sign In
Register
News
Events
Articles
Product Center
Featured Products
Videos
Register
Sign In
AdGlare Leaderboard
OphthalmologyWeb
Refractive
Product Center
Retina Products and Equipment
Vitreoretinal Surgery
Radiation Plaques
Radiation Plaques
Showing 3 of 3 products
<<
<
>
>>
Sort By
- select -
Item Name
Company Name
Price
Select All
Select up to 5 products from below to compare or request more information.
Compare
Compare
for selected.
IsoSeed® I-125 (I25.S06)
Bebig
Indications:
The Isoseeds® I-125 are used for interstitial seed implantation therapy of localized tumors, especially in the prostate. Treatment of tumors in a generally bad or ulcerated state is not recommended. Implantation of the Isoseeds® I-125 shall only be carried out by appropriately trained medical experts trained for brachytherapy.
Isotope:
Iodine-125
Half-Life:
59.46 days
Read More
Inquire
Compare
for selected.
Non-Sterile Oncoseed (Iodine-125 Seeds)
Oncura
Indications:
Oncoseed seeds with apparent activities from 0.191 to 1.01 mCi are indicated for permanent interstitial implantation of selected localized tumors which are of low to moderate radiosensitivity. They may be used either as primary treatment (such as for prostate cancer or unresectable tumors) or for treatment of residual disease after excision of the primary tumor. Seeds in this apparent activity range may be used to treat superficial, intraabdominal, and intrathoracic tumors. Tumors of the head, neck, lung, pancreas, and prostate (early stages) commonly treated. Oncoseed seeds with total apparent activities greater than 1.01 mCi are indicated for interstitial treatment of tumors which have the following characteristics: unresectable, localized, and moderate radiosensitivity. These seeds may be used for selected radiation applications as temporary implants.
Isotope:
Iodine-125
Half-Life:
59.43 day Half-Life1
Read More
Inquire
Compare
for selected.
Oncoseed Sterile Convenience Pack (Iodine-125 Seeds)
Oncura
Indications:
Oncoseed seeds with apparent activities from 0.191 to 1.01 mCi are indicated for permanent interstitial implantation of selected localized tumors which are of low to moderate radiosensitivity. They may be used either as primary treatment (such as for prostate cancer or unresectable tumors) or for treatment of residual disease after excision of the primary tumor. Seeds in this apparent activity range may be used to treat superficial, intraabdominal, and intrathoracic tumors. Tumors of the head, neck, lung, pancreas, and prostate (early stages) commonly treated. Oncoseed seeds with total apparent activities greater than 1.01 mCi are indicated for interstitial treatment of tumors which have the following characteristics: unresectable, localized, and moderate radiosensitivity. These seeds may be used for selected radiation applications as temporary implants.
Isotope:
Iodine-125
Half-Life:
59.43 day Half-Life1
Read More
Inquire
Select All
Select up to 5 products from above to compare or request more information.
Compare
Tags:
Please Login or Register to Create Tags
Feedback
Help
Use this product listing in multiple ways:
Click
Get Quote
to receive a quote from the vendor for that product
Check up to 5 products and click to
compare
to view product specifications side by side or
Get quote
to get a quote for all your selected products
Click
Get quotes for all products
at the top of the list to get a quote for all products
advertisement
Related Articles
NIDEK Announces Winners of IMAGEs OF THE YEAR ...
Tuesday, April 11, 2023
FDA Approves SYFOVRE, the First Treatment for ...
Thursday, March 02, 2023
FDA-Cleared FullRange SD-OCT Now Available in ...
Tuesday, February 14, 2023
Helen Keller Foundation Publishes Prevention ...
Monday, January 30, 2023
Maintaining ACE2 in the Gut May Prevent Diabetic ...
Tuesday, January 24, 2023
AdGlare RMR2